Reduce development risk with the right expertise
Inhalation is often used to treat conditions in the respiratory system and the lungs, for example COPD or asthma. The drug reaches its target…
Meet us at Bio International, San Diego , June 13-16
In June, Iconovo will attend the conference Bio International to meet new customers and partners. Roger Lassing, VP Business Development, is happy to book…
Interim Report for Q1 2022 available in English
The abbreviated Interim Report for January to March 2022 is now avaialble in English.
Read it here
Iconovo and Galenica enters a strategic collaboration for the development of new inhalation products
Iconovo has entered into a strategic collaboration with Galenica AB – a company specializing in the development and manufacture of pharmaceuticals…
Quarterly Report for Q1 2022 released
The Quarterly Report for Q1 2022 was released today and is available here, in Swedish.
Annual Report 2021 released
The Annual Report for 2021 is now available for download from Iconovo´s website. The Annual Report is in Swedish and an English version is yet to be …
Meet Iconovo at RDD, Orlando
A team from Iconovo will visit RDD, Respiratory Drug Delivery in beginning of May, in Orlando. There will be an exhibition from Iconovo with inhalation…
Presentation från Erik Penser Bank Health Care Day
Roger Lassing, VP Business Development på Iconovo, presenterade företaget på Erik Penser Hetlh Care Day den 24 februari 2022 och presentationen…
Iconovo Q4-2021 quarterly report
Significant progress in Iconovo’s three strategic business areas
Significant events 1 October – 31 December
Iconovo signed an agreement…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se